Omron (OTCMKTS:OMRNY) Sees Large Volume Increase – Time to Buy?

Omron Corp. (OTCMKTS:OMRNY) saw strong trading volume on Thursday . 433,559 shares changed hands during mid-day trading, an increase of 755% from the previous session’s volume of 50,706 shares.The stock last traded at $27.70 and had previously closed at $29.10.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Omron from a “strong sell” rating to a “hold” rating in a report on Monday, January 19th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

Omron Price Performance

The company has a market cap of $5.77 billion, a P/E ratio of 35.44, a price-to-earnings-growth ratio of 0.33 and a beta of 1.00. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.37 and a current ratio of 2.11. The business’s fifty day moving average is $29.61 and its two-hundred day moving average is $27.58.

Omron (OTCMKTS:OMRNY) last issued its earnings results on Thursday, February 5th. The company reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). Omron had a return on equity of 2.46% and a net margin of 2.80%.The company had revenue of $1.41 billion during the quarter, compared to the consensus estimate of $1.38 billion. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Equities analysts predict that Omron Corp. will post 0.42 EPS for the current year.

Institutional Investors Weigh In On Omron

A hedge fund recently raised its position in Omron stock. GAMMA Investing LLC lifted its position in Omron Corp. (OTCMKTS:OMRNY) by 50.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,129 shares of the company’s stock after acquiring an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent SEC filing. Institutional investors and hedge funds own 1.09% of the company’s stock.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.